Poverty, Disease and Drugs in Regional Development
Main Article Content
Abstract
It is indeed an honour and a great privilege to be given an opportunity to address such a select group of professional colleagues represented at this 24th Annual General Meeting and Scientific Symposium of the West African Post Graduate College of Pharmacists. In this presentation on poverty, disease and drugs in regional development I will start by describing the key words in the topic and then proceed to look at the interplay of these factors in the process of regional development through a concept I have tagged the tripod of underdevelopment and then end with the role of the pharmacist in regional development.
Downloads
Article Details
How to Cite
Share
References
http://hdr.undp.org/en/humandev/
Sen, A. (1999) Development as Freedom. Oxford: Oxford University Press.
Human Development Report: International Human Indicators Indices. http://hdr.undp.org/en/statistics/
Residential Energy Consumption Survey (2005): Detailed Tables. http://rfflibrary.wordpress.com/2008/1/23/2005-residential-energy-consumptionsurvey-detailed-
Rector, R and Sheffield, R. Backgrounder , Published by Heritage Foundation: No. 2575July18,2011http://report.heritage.org/bg2575
Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Sachs E & Sachs JD. (2006).
Incorporating a rapid-impact package for neglected tropical disease with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Medicine, 3(5): e102
doi:10.1371/journal/pmed./0030102.
Yamey G & Hotez P (2007). Neglected tropical diseases. BMJ, 335: 269-70
Kate Davies. (2005) Economic Costs of Diseases and Disabilities Attributable to
Environmental Contaminants in Washington State. Collaborative for Health and Environment Washington Research and Information WorkingGroup.http://washington.chenw.org/pdfs/EnvironmentalCosts.pdf
Chan, M. Opening statement at the launch of the WHO report, Working to overcome the global impact of neglected tropical disease. Geneva, Switzerland. 14 October 2010.
Hotez PJ & Ferris MT. (2006). The antipoverty vaccines. Vaccine, 24:5787-
Hotez PJ & Bethony JM. (2008). "Parasitic disease vaccines." Vaccines, 5th Ed. Eds. Plotkin SA, Orenstein WA & Offit PA. Elsevir, Inc., Philadelphia, PA.
Zeisel, C. West Africa is still a hub for international drug trafficking.
Http://www.allwestafrica.com/020320120349.html
The Brenthurst Foundation. Maritime Development In Africa: An Independent Specialists' Framework Brenthurst. Discussion Paper 2010 / 03
United Nations Office on Drugs and Crime. (2008). “Drug Trafficking as a Security Threat in West Africa”
Alkire, S. (2002) Valuing Freedoms. Oxford: Oxford University Press.
Rios, V. Evaluating the economic impact of drug traffic in Mexico. https://www.gov.harvard.edu/files/MexicandrugMarket_Riosv2-14.pdf
AU/NEPAD African Action Plan (Updated Final Draft Version, 28 March 2008)
UNODC ( West & Central Africa). The problem of Drug and Organized crime in West and Central Africa. http://www.unodc.org/westandcentralafrica/en/regional-programme-framework.html
World Drug Report (2010). http://www.unodc.org/documents/wdr/
WDR_2010/World_Drug_Report_2010_lo-res.pdf
Erhun W.O., Babalola, O.O. and Erhun, M.O.(2001) “Drug Regulation and control in Nigeria. -The challenge of counterfeit drugs” Journal of Health and Population in Developing Countries 4(2), 23 – 34.
http://www.bbc.co.uk/news/health-16588153
Pharmacists Fault NAFDAC on Fake Drugs. The Daily Trust (Nigeria) | October 22, 2010.http://www.accessmylibrary.com/article- 1G1-240181235/pharmacistsfault-nafdac-fake.html
Baldeh, P. Burning Issues: President of Pharmaceutical Society on Fake Malaria Drugs.http://www.foroyaa.gm/modules/news/article.php?storyid=8742
NAFDAC. Brief on contaminated “My Pikin baby teething mixture”: report of
investigation and regulatory action by NAFDAC. Pharmacovigilance. FDIC News.
(1), 2009.
Effects of Counterfeit Drugs on Human Life http://sproxil.com/effectsofcounterfeits.php
World Health Organisation. (2010) Medicines: spurious/falsely-labelled/
falsified/counterfeit (SFFC) medicines. http://www.who.int/mediacentre/factsh
eets/fs275/en/
The Holy Bible: Proverbs 11: 28,29; & 10: 15.( King James Version)
The Holy Bible: Proverbs 28:22 (King James Version)
Www.makepovertyhistory.org /docs/mandelaspeech.doc
Spice Digest (2009). Diseases of Poverty: Neglected Tropical Infections in Sub
Http://www.cdc.gov/ncidod/dvbid/Chikungunya/
Hoskin, K. “The Vaccine Industry”. hoskinsk@nursing.upenn.edu
Newton, P.N.,Green, M.D and Fernández, F.M.(2010) Trends in Pharmacological Sciences. Volume 31(1), 99 – 101.
Schenkel S.( 2000). Promoting patient safety and preventing medical error in
emergency departments. Acad Emerg Med;7:1204-1222
Peth HA.( 2003). Medication errors in the emergency department: A systems
approach to minimizing risk. Emerg Med Clin North Am; 21: 141-158.
ChassenDC, et al. JAMA 1997;277:301-306
Society of Actuaries' Health Section (2010). The Economic Measurement of
MedicalErrorshttp://www.soa.org/files/pdf/research-econ-measurement.pdf.
WHO Third Consultative group report on the Role of the Pharmacist in the Health care system- preparing the future pharmacists: Curricular development ,
Vancouver, Canada, 27 – 29 August 1997 13 West African Journal of Pharmacy (2012) 23 (2)
Erhun, W.O. “ A tree model for managing medicine use and supply” 239th Inaugural lecture of the Obafemi Awolowo University delivered at Oduduwa hall, Obafemi Awolowo University, Ile Ife on Tuesday, 24th May 2011.
Erhun, W.O “ Acesssing health care through Pharmacy” Presentation at the
th PSN Annual National Conference Symposium. Jalingo, Taraba state, Nigeria.
November2010.Psnnational.org/.../accessing-healthcare-through-pharmacy.
Erhun, W.O., Agbani, E.O and Bolaji, E.E. (2005) “Positive benefits of a pharmacistmanaged hypertension clinic in Nigeria” Public Health 119(9), 792-798.
Erhun W.O., Adekoya A..O, Erhun, M.O. and Bamgbade, O.O. (2009), “Legal Issues in Prescription Writing: A Study of Two Health Institutions in Nigeria”
International Journal of Pharmacy Practice. 17: 1–5.